The Supreme Court will hear arguments this week in several high-stakes cases, including a dispute over tribal healthcare programs and a landmark hearing that could determine the scope of access to the common abortion pill.
The highlight of the week will be on Tuesday in a pair of consolidated cases against the Food and Drug Administration‘s actions over the abortion drug mifepristone, which in 2016 made changes to allow the pill to be more widely accessible by online order or mail delivery.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.